Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle Cell Disease Health Disparities
source: CDC Foundation
Sickle cell disease (SCD) is the world’s most common genetic disease, affecting approximately 100,000 people in the United States. As a group, people with SCD experience worse health outcomes compared to other diseases and have access to fewer health resources. This lack of equality is termed a health disparity.
Through a partnership with the Centers for Disease Control and Prevention’s Division of Blood Disorders, Tracking California and the Georgia Health Policy Center, the CDC Foundation is implementing the Sickle Cell Data Collection (SCDC) program to collect health information about people with SCD to study long-term trends in diagnosis, treatment and healthcare access. The SCDC program aims to use study findings to inform policy and health care changes that decrease health disparities for people with SCD.
The project is receiving funding support from Pfizer Inc., Bioverativ and Global Blood Therapeutics and is active in California and Georgia. Additional support is needed to expand the program to all of the United States to improve the disparate state of SCD.read more
2022 PCORI Annual MeetingThe PCORI Annual Meeting brings together...
Flying doctor takes to the skies after sister’s deathOlamide Orekunrin was studying to become...
Susan Claster, MDDr. Claster graduated from the Universit...
Johns Hopkins Berman Institute of BioethicsEstablished in 1995, the Berman Institut...
Yale New Haven HospitalMedical teams at Yale New Haven Hospital...
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...
Sickle Cell Disease in the Emergency Department: Confronting Barriers to Care“You’re too pretty to have a disease...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.